MedTrace Logo

Driveline Silicone Skin Interface Registry

NCT01577433 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-03-13

No results posted yet for this study

Summary

The purpose of this observational registry is to determine the freedom from driveline (DL) infection events in subjects implanted with a HeartMate II LVAD in whom only the silicone portion of the DL is externalized resulting in a silicone skin interface (SSI)

Conditions

  • Driveline Heart-assisted Device Related Infection

Sponsors & Collaborators

  • Thoratec Corporation

    collaborator INDUSTRY

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • David Farrar, PhD · Abbott Medical Devices

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2018-07-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01577433 on ClinicalTrials.gov